"Thromboembolism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream.
| Descriptor ID |
D013923
|
| MeSH Number(s) |
C14.907.355.590
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thromboembolism".
Below are MeSH descriptors whose meaning is more specific than "Thromboembolism".
This graph shows the total number of publications written about "Thromboembolism" by people in this website by year, and whether "Thromboembolism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 1 | 0 | 1 |
| 1997 | 3 | 0 | 3 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 4 | 0 | 4 |
| 2004 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 3 | 2 | 5 |
| 2009 | 0 | 1 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 1 | 1 |
| 2014 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 2 | 3 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thromboembolism" by people in Profiles.
-
Low-Dose vs Standard Warfarin After Mechanical Mitral Valve Replacement: A?Randomized Trial. Ann Thorac Surg. 2023 04; 115(4):929-938.
-
Edoxaban versus Vitamin K Antagonist for Atrial Fibrillation after TAVR. N Engl J Med. 2021 12 02; 385(23):2150-2160.
-
Age and Comorbidities Impact Medical Complications and Mortality Following Free Flap Reconstruction. Laryngoscope. 2022 04; 132(4):772-780.
-
Early anticoagulant reversal after trauma: A Western Trauma Association critical decisions algorithm. J Trauma Acute Care Surg. 2021 02 01; 90(2):331-336.
-
Using the Case-Crossover Design to Assess Short-Term Risks of Bleeding and Arterial Thromboembolism After Switching Between Oral Anticoagulants in a Population-Based Cohort of Patients With Atrial Fibrillation. Am J Epidemiol. 2020 12 01; 189(12):1467-1477.
-
Predictors of Warfarin Time in Therapeutic Range after Continuous-Flow Left Ventricular Assist Device. Pharmacotherapy. 2019 10; 39(10):1030-1035.
-
Edoxaban Versus standard of care and their effects on clinical outcomes in patients having undergone Transcatheter Aortic Valve Implantation in Atrial Fibrillation-Rationale and design of the ENVISAGE-TAVI AF trial. Am Heart J. 2018 11; 205:63-69.
-
Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation. Pharmacoepidemiol Drug Saf. 2018 04; 27(4):383-390.
-
Response to Comment on O'Brien et al. Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes. Diabetes Care 2017;40:233-238. Diabetes Care. 2017 05; 40(5):e62.
-
Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes. Diabetes Care. 2017 Feb; 40(2):233-238.